BioSpace News Archive

FDA

Myriad’s BRACAnalysis CDx® Supplementary PMA Accepted by FDA for Review as a Companion Diagnostic for Talazoparib in Metastatic Breast Cancer

Myriad Genetics, Inc. announced that the U.S. Food and Drug Administration (FDA) has accepted its supplementary premarket approval (sPMA) application for BRACAnalysis CDx® to be used as a companion diagnostic with Pfizer’s PARP

July 5, 2018
·
7 min read
Arbutus Biopharma to Present at First Annual Roivant Pipeline Day

Arbutus Biopharma Corporation announced that it will present at the first annual Roivant Pipeline Day on July 10, 2018, at 4:00 p.m. ET.

July 5, 2018
·
1 min read
Business

AngioSoma, Inc. Announces Selection of Regulatory Firm for Flagship Drug

AngioSoma, Inc. is excited to announce that we have identified a regulatory firm who can assist taking our patented flagship drug, Liprostin™, through the FDA approval process.

July 5, 2018
·
1 min read
Deals

MTBC Announces Results from Annual Shareholders Meeting

MTBC announced that its shareholders held their 2018 annual meeting on June 15, 2018 and voted on three proposals.

July 5, 2018
·
4 min read
Deals

OptimizeRx Uplists to the Nasdaq Capital Market

OptimizeRx Corp. has uplisted to the Nasdaq Capital Market, with its common stock to commence trading on the exchange beginning Friday, June 22, 2018 under the symbol, “OPRX.”

July 5, 2018
·
2 min read
Genetown

Biogen to Host Investor Webcast on Its Efforts Targeting Stroke on June 28, 2018

Biogen announced it will host a live webcast providing an overview of its efforts targeting acute ischemic stroke on Thursday, June 28, 2018.

July 5, 2018
·
1 min read
Business

Easton Pharmaceuticals Announces New Director / Officer to Its Board and Updates to Business Direction

Easton Pharmaceuticals Inc. is pleased to announce a new director and officer to its board with the appointment of Mr. Vince Demasi of Alliance Group, as Chief Operating Officer & Director, and updates to business direction.

July 5, 2018
·
4 min read
Clinical data demonstrates significantly increased cure rates using Resistance Guided Therapy for treating the STI Superbug M. genitaliumSpeeDx ResistancePlus® MG test supports new STI management guidelines

SpeeDx Pty. Ltd. announced clinical data contained in a new study published in the June 2018 issue of Clinical Infectious Diseases

July 5, 2018
·
5 min read
BioMidwest

Top-Five National Payer Issues Positive Coverage Decision for Myriad’s Prolaris® Test for Prostate CancerDecision Follows Recently Updated Medical Guidelines for Prostate Cancer

Myriad Genetics, Inc. announced that it has received a positive medical policy decision for its Prolaris®

July 5, 2018
·
6 min read
Business

Syneos Health and Elligo Announce Strategic Collaboration to Advance Clinical Research for Real-World Patients

Syneos Health™ and Elligo Health Research are entering a strategic collaboration to mobilize a system of accelerated research to reach real-world patients.

July 5, 2018
·
5 min read